Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Innovation Fund Boosts Commercialization of Purdue Technologies

Published: Thursday, January 31, 2013
Last Updated: Thursday, January 31, 2013
Bookmark and Share
Purdue University innovations in research areas including personal health monitoring, advanced diabetes treatment and energy-efficient metal sheet processing, received more than $260,000 in the most recent round of awards through the Trask Innovation Fund.

The Purdue Research Foundation-managed Trask Innovation Fund is a technology development program to assist faculty who have disclosed a discovery to the Purdue Office of Technology Commercialization.

"The Trask Innovation Fund provides critical financial support to Purdue researchers who have patented a technology but need to develop a prototype or finalize research data that supports the discovery’s move to the public," said Joseph B. Hornett, senior vice president, treasurer and COO of the Purdue Research Foundation.

The 10-member Trask Innovation Advisory Council is composed of external business executives and representatives from the Purdue Research Foundation, Purdue University Office of the Vice President for Research and Purdue faculty researchers.

"The process is competitive and the recipients must demonstrate how the discovery will meet a public need, how soon the technology can be commercialized, and how the Trask funds will help the researcher advance its development," said Richard O. Buckius, Purdue's vice president for research and co-director of the Trask Advisory Council.

Project managers from the Purdue Office of Technology Commercialization collaborate with Purdue researchers to move their discoveries through the patent and commercialization process.

"One of our primary goals is to encourage and support the development of new products that have commercial potential," said Elizabeth Hart-Wells, assistant vice president of the Purdue Office of Technology Commercialization and co-director of the Trask Advisory Council. "Each of our project managers is specialized in a specific discipline, and they work directly with researchers to protect Purdue’s intellectual property, and to translate and ultimately license a new technology to appropriate industry partners."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Friday, April 22, 2016
Scientific News
Manufactured Stem Cells To Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Manufactured Stem Cells to Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Starving Stem Cells May Enable Scientists To Build Better Blood Vessels
Researchers from the University of Illinois at Chicago College of Medicine have uncovered how changes in metabolism of human embryonic stem cells help coax them to mature into specific cell types — and may improve their function in engineered organs or tissues.
Long-Term Culturing of Adult Stem Cells
A new procedure developed by Harvard Stem Cell Institute researchers (HSCI) at Massachusetts General Hospital (MGH) may revolutionize the culturing of adult stem cells.
Naked Mole Rat Exhibits “Extraordinary” Cancer Resistance
Scientists are getting closer to understanding the anti-cancer mechanism of the naked mole rat by making induced pluripotent stem cells.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
Reclaiming The Immune System's Assault On Tumors
EPFL study shows a way to reclaim corrupted immune cells.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Body’s Own Gene Editing System Generates Leukemia Stem Cells
Inhibiting the editing enzyme may provide a new therapeutic approach for blood cancers.
Cirrhosis-Causing Cells Converted to Healthy Liver Cells in Mice
New approach that repairs liver from within may be more efficient than cell transplants.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!